| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Address all correspondence and requests for reprints to: Willis K. Samson, Ph.D., Professor and Chairman, Department of Physiology, University of North Dakota School of Medicine, Grand Forks, North Dakota 58202.
|
|
|---|
Using cultured hypothalamic cells and the immortalized GnRH-producing GT17 cells, Krsmanovic et al. (1) have demonstrated both nicotinic and muscarinic actions of ACh that underlie its biphasic effects on GnRH release. Does this system provide a model for the biphasic effects of other factors on hormone/peptide release? Are the initial stimulatory and subsequent inhibitory effects of other trophic factors not truly dose related, but instead a function of activation (with differing latencies) of multiple ligand receptors on the same or neighboring cells? Could this be the reason for the troublesome, but ever present, bell-shaped dose-response curves that we are loathe to explain to our students?
This manuscript (1) not only characterizes the nicotinic/muscarinic ying/yang effect of ACh but also identifies the intracellular signaling mechanisms recruited, including the remarkable time course of G protein subunit activations. Even within the muscarinic actions, there are both stimulatory (M1 receptor mediated) and inhibitory (M2 receptor mediated) effects and those have been linked to unique cellular mechanisms. The report raises several questions, and thus the never ending story seems to continue on, refreshed by these insightful observations. Clearly, both cultured and immortalized cells must express the multiple receptors, but how does the GnRH neuron in its normal, in vivo setting know how (and when) to respond? Are all cholinergic receptors on these cells activated in parallel, or are there some unknown mechanisms by which some receptor subtypes become activated (i.e. up-regulated or sensitized), while others go silent? Even more enticing is the suggestion from the atropine and methoctramine study that these cells themselves produce ACh, which can act in an autocrine fashion to regulate GnRH release, and perhaps even receptor subtype expression. As Catt and colleagues have demonstrated, technology has now advanced to the point where those questions can be addressed. Their group certainly is leading the way. However, the puzzle has many parts and the picture will not be completed until the interactions of the cholinergic system with other aminergic and peptidergic regulators of GnRH have been characterized. Then the most important and difficult questions can be addressed: Why the incredible redundancy (a.k.a. cooperativity) of multiple regulatory factors and how are they coordinated? This work has completed a portion of the puzzle and importantly may have revealed how many more pieces remain missing.
Willis K. Samson, Ph.D.
Professor and Chairman
Department of Physiology
University of North Dakota School of Medicine
Grand Forks, North Dakota 58202
Received August 1, 1998.
| References |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |